Nice roundup of #PBM formularies and coverage of #Humira #biosimilars in 2024 vs. 2025.
Source: AIS Health
Transparency works! Today's FTC report on PBMs & generic specialty Rx $ uses @mcuban.bsky.social @costplusdrugs.com as baseline reference in reality based wholesale/retail pricing models.
www.ftc.gov/system/files...
PBMs sell chronic disease mgmt services (via subsidiary) under the guise of a "care team" model & ⬆️ treatment plan adherence. They're paid to monitor & intervene w/in the broken system they've designed. Another form of #patientsteering
A formulary is virtual shelf space for sale.
